Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Frank Bennett

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Science Translational Medicine|January 27, 2017
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathySarah L DeVos, Rebecca L Miller, Kathleen M Schoch, et al.
Neurology|April 26, 2019
Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studiesBasil T Darras, Claudia A Chiriboga, Susan T Iannaccone, et al.
Nature Communications|August 11, 2015
DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencingKazutaka Nishina, Wenying Piao, Kie Yoshida-Tanaka, et al.
American Journal of Human Genetics|August 9, 2016
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA PhenotypeSeyyedmohsen Hosseinibarkooie, Miriam Peters, Laura Torres-Benito, et al.
Nature Neuroscience|January 16, 2019
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegenerationZe'ev Melamed, Jone López-Erauskin, Michael W Baughn, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Nucleic Acids Research|November 11, 2015
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcriptsSebastien A Burel, Christopher E Hart, Patrick Cauntay, et al.
Science Translational Medicine|October 25, 2013
Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansionDhruv Sareen, Jacqueline G O'Rourke, Pratap Meera, et al.
Journal of Medicinal Chemistry|April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseAnne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Nature Biotechnology|August 13, 2021
Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNSTetsuya Nagata, Chrissa A Dwyer, Kie Yoshida-Tanaka, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Science Translational Medicine|January 27, 2017
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathySarah L DeVos, Rebecca L Miller, Kathleen M Schoch, et al.
Neurology|April 26, 2019
Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studiesBasil T Darras, Claudia A Chiriboga, Susan T Iannaccone, et al.
Nature Communications|August 11, 2015
DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencingKazutaka Nishina, Wenying Piao, Kie Yoshida-Tanaka, et al.
American Journal of Human Genetics|August 9, 2016
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA PhenotypeSeyyedmohsen Hosseinibarkooie, Miriam Peters, Laura Torres-Benito, et al.
Nature Neuroscience|January 16, 2019
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegenerationZe'ev Melamed, Jone López-Erauskin, Michael W Baughn, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Nucleic Acids Research|November 11, 2015
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcriptsSebastien A Burel, Christopher E Hart, Patrick Cauntay, et al.
Science Translational Medicine|October 25, 2013
Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansionDhruv Sareen, Jacqueline G O'Rourke, Pratap Meera, et al.
Journal of Medicinal Chemistry|April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseAnne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Nature Biotechnology|August 13, 2021
Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNSTetsuya Nagata, Chrissa A Dwyer, Kie Yoshida-Tanaka, et al.
Pageof 17